Abstract
Headache is a common symptom of brain tumors. Here we will review the epidemiology, clinical characteristics and management of the brain tumor headache. The classic brain tumor headache, typically progressive, worse in the morning and aggravated by Valsalva-like maneuvers, is an uncommon occurrence in clinical practice. Brain tumor headaches can present similarly to primary headaches in individuals predisposed to headaches. This suggests that there may be a shared pathophysiology between the primary headaches and the brain tumor headache. Patients with a history of headaches should undergo neuroimaging if the headache is accompanied by new symptoms, abnormal neurological exam or is different from their usual headache. New onset headache patients should be imaged if the headache is progressive, severe, associated with nausea or vomiting or an abnormal neurological exam. The treatment of the brain tumor headache should be tailored according to the specific etiology of the headache. A rigorous management of the brain tumor headache will contribute to preservation of quality of life in brain tumor patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- MRI:
-
Magnetic resonance imaging
- ICHD:
-
International classification of headache disorders
- CSF:
-
Cerebrospinal fluid
- ICP:
-
Intracranial pressure
- CNS:
-
Central nervous system
- ATAC trial:
-
Arimidex, Tamoxifen, Alone or in combination trial
- SMART syndrome:
-
Stroke-like migraine attacks after radiation therapy syndrome
- PRES:
-
Posterior reversible encephalopathy syndrome
- AZT:
-
Azidothymidine
- DDI:
-
Didanosine
- PCNU:
-
1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea
- OKT3:
-
Murine monoclonal anti-CD3 antibody
- GM-CSF:
-
Granulocyte-macrophage colony-stimulating factor
References
Kahn K, Finkel A. It is a tumor—current review of headache and brain tumor. Curr Pain Headache Rep. 2014;18(6):421.
Suwanwela N, Phanthumchinda K, Kaoropthum S. Headache in brain tumor: a cross-sectional study. Headache. 1994;34(7):435–8.
Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43(9):1678–83.
Pfund Z, Szapary L, Jaszberenyi O, Nagy F, Czopf J. Headache in intracranial tumors. Cephalalgia. 1999;19(9):787–90; discussion 65.
Nelson S, Taylor LP. Headaches in brain tumor patients: primary or secondary? Headache. 2014;54(4):776–85.
The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
Taylor LP. Mechanism of brain tumor headache. Headache. 2014;54(4):772–5.
Jaeckle KA. Causes and management of headaches in cancer patients. Oncology (Williston Park). 1993;7(4):27–31; discussion-2, 4.
Kunkle EC, Ray BS, Wolff HG. Studies on headache: the mechanisms and significance of the headache associated with brain tumor. Bull N Y Acad Med. 1942;18(6):400–22.
Lundberg N. Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psychiatr Scand Suppl. 1960;36(149):1–193.
Rosner MJ, Becker DP. Origin and evolution of plateau waves. Experimental observations and a theoretical model. J Neurosurg. 1984;60(2):312–24.
Yokoyama S, Mamitsuka K, Tokimura H, Asakura T. Headache in pituitary adenoma cases. J Jpn Soc study Chron Pain. 1994;13:79–82.
Levy MJ, Matharu MS, Meeran K, Powell M, Goadsby PJ. The clinical characteristics of headache in patients with pituitary tumours. Brain. 2005;128(Pt 8):1921–30.
Connor M, Bagley EE, Mitchell VA, Ingram SL, Christie MJ, Humphrey PP, et al. Cellular actions of somatostatin on rat periaqueductal grey neurons in vitro. Br J Pharmacol. 2004;142(8):1273–80.
Otsuka F, Kageyama J, Ogura T, Makino H. Cluster headache dependent upon octreotide injection. Headache. 1998;38(8):629.
Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol. 2004;56(4):488–94.
Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol. 2002;1(4):251–7.
Peres MF, Sanchez del Rio M, Seabra ML, Tufik S, Abucham J, Cipolla-Neto J, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001;71(6):747–51.
Peroutka SJ. Dopamine and migraine. Neurology. 1997;49(3):650–6.
Levy MJ, Jager HR, Powell M, Matharu MS, Meeran K, Goadsby PJ. Pituitary volume and headache: size is not everything. Arch Neurol. 2004;61(5):721–5.
Gondim JA, de Almeida JP, de Albuquerque LA, Schops M, Gomes E, Ferraz T. Headache associated with pituitary tumors. J Headache Pain. 2009;10(1):15–20.
Abe T, Matsumoto K, Kuwazawa J, Toyoda I, Sasaki K. Headache associated with pituitary adenomas. Headache: J Head Face Pain. 1998;38(10):782–6.
Clouston PD, DeAngelis LM, Posner JB. The spectrum of neurological disease in patients with systemic cancer. Ann Neurol. 1992;31(3):268–73.
Jena SS, Nayak S, Behera IC, Mohapatra D, Tripathy SK. Cerebral venous sinus thrombosis: an unusual initial presentation of mucinous adenocarcinoma of stomach. Neurol India. 2014;62(6):695–7.
Ferro JM, Canhão P, Stam J, Bousser M-G, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke. 2004;35(3):664–70.
Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology. 2000;54(6):1222–6.
Iurlaro S, Silvani A, Mauri M, Truci G, Beretta S, Zilioli A, et al. Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series. Neurol Sci. 2015;36(Suppl 1):149–51.
Greenberg HS, Deck MD, Vikram B, Chu FC, Posner JB. Metastasis to the base of the skull: clinical findings in 43 patients. Neurology. 1981;31(5):530–7.
Laigle-Donadey F, Taillibert S, Martin-Duverneuil N, Hildebrand J, Delattre J-Y. Skull-base metastases. J Neurooncol. 2005;75(1):63–9.
Tamoxifen tablets [package insert]. Morgantown, WV: Mylan Pharmaceuticals Inc.; 2013.
Sul JK, DeAngelis LM. Neurologic complications of cancer chemotherapy. Semin Oncol. 2006;33(3):324–32.
Ganguly S. All-trans retinoic acid related headache in patients with acute promyelocytic leukemia: prophylaxis and treatment with acetazolamide. Leuk Res. 2005;29(6):721.
Thielen AM, Saurat JH. Retinoids. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. China: Elsevier; 2012. p. 2089–103.
Colucciello M. Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia. Arch Ophthalmol. 2003;121(7):1064–5.
Kirby S, Purdy RA. Headaches and brain tumors. Neurol Clin. 2014;32(2):423–32.
Shuper A, Packer R, Vezina L, Nicholson H, Lafond D. Complicated migraine-like episodes’ in children following cranial irradiation and chemotherapy. Neurology. 1995;45(10):1837–40.
Black DF, Morris JM, Lindell EP, Krecke KN, Worrell GA, Bartleson JD, et al. Stroke-like migraine attacks after radiation therapy (SMART) syndrome is not always completely reversible: a case series. AJNR Am J Neuroradiol. 2013;34(12):2298–303.
Kerklaan JP, Lycklama á Nijeholt GJ, Wiggenraad RGJ, Berghuis B, Postma TJ, Taphoorn MJB. SMART syndrome: a late reversible complication after radiation therapy for brain tumours. J Neurol. 2011;258(6):1098–104.
Farid K, Meissner WG, Samier-Foubert A, Barret O, Menegon P, Rouanet F, et al. Normal cerebrovascular reactivity in stroke-like migraine attacks after radiation therapy syndrome. Clin Nucl Med. 2010;35(8):583–5.
Gilles F. The epidemiology of headache among children with brain tumor. J Neurooncol. 1991;10(1):31–46.
Abu-Arafeh I, Macleod S. Serious neurological disorders in children with chronic headache. Arch Dis Child. 2005;90(9):937–40.
Reulecke BC, Erker CG, Fiedler BJ, Niederstadt T-U, Kurlemann G. Brain tumors in children: initial symptoms and their influence on the time span between symptom onset and diagnosis. J Child Neurol. 2008;23(2):178–83.
Wilne SH, Ferris RC, Nathwani A, Kennedy CR. The presenting features of brain tumours: a review of 200 cases. Arch Dis Child. 2006;91(6):502–6.
Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, et al. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96(1):103–14.
Schiff D, Lee EQ, Nayak L, Norden AD, Reardon DA, Wen PY. Medical management of brain tumors and the sequelae of treatment. Neuro Oncol. 2015;17(4):488–504.
Bruera E, Paice JA. Cancer pain management: safe and effective use of opioids. Am Soc Clin Oncol Educ Book. 2015;35:e593–9.
Hayashi N, Kidokoro H, Miyajima Y, Fukazawa T, Natsume J, Kubota T, et al. How do the clinical features of brain tumours in childhood progress before diagnosis? Brain Dev. 2010;32(8):636–41.
Molineus A, Boxberger N, Redlich A, Vorwerk P. Time to diagnosis of brain tumors in children: a single-centre experience. Pediatr Int. 2013;55(3):305–9.
David SC, Kesari S, Patrick Y. Wen, (Eds) Cancer Neurology in Clinical Practice: Neurologic Complications of Cancer and Its Treatment. 2008
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Ranjan, S., Schiff, D. (2018). Headache as Complication of Cancer. In: Schiff, D., Arrillaga, I., Wen, P. (eds) Cancer Neurology in Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-57901-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-57901-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57899-6
Online ISBN: 978-3-319-57901-6
eBook Packages: MedicineMedicine (R0)